Skip to content

CPAP Reduces Hypoxemia After Cardiac Surgery

CPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01726140
Acronym
CRHACS
Enrollment
407
Registered
2012-11-14
Start date
2013-04-30
Completion date
2024-01-31
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure Requiring Reintubation

Keywords

intubation, respiratory failure, cardiac surgery

Brief summary

The aim of study is to evaluate whether the application of a continuous positive airway pressure (CPAP) after extubation in patients undergoing cardiac surgery can reduce hypoxemia and re-intubation rate.

Detailed description

We want to test the hypothesis that the application of a continuous positive airway pressure (CPAP) after extubation in patients undergoing cardiac surgery can reduce hypoxemia and re-intubation rate. Primary end point: to reduce the rate of re-intubation. Secondary end point: to reduce the incidence of atelectasis, pneumonia, sepsis, the mortality rate, the intensive care unit (ICU) and hospital length of stay.

Interventions

PROCEDUREHelmet CPAP

the patient will receive CPAP treatment, at a PEEP level of 10 cmH2O and a FiO2 adjusted to maintain SpO2\>95%, for six hours. After three hours of treatment a blood gas analysis will be evaluated and the patient will proceed with the treatment for three more hours. At the end of the six hours, the patient will repeat a spontaneous breathing trial with a Venturi mask at FiO2 = 50%, for 15 minutes and than a blood gas analysis will be repeated: if the PaO2/FiO2 will be \< 200 the patient will received a second treatment with CPAP; if PaO2/FiO2 will be \>200, the patient will stop the treatment.

PROCEDUREVenturi Mask

the patient will maintain spontaneous breathing, with a system for oxygen delivery at a FiO2 adjusted to maintain SpO2\>95%, for six hours. After three hours of treatment a blood gas analysis will be evaluated and the patient will proceed with the treatment for three more hours. At the end of the six hours, the patient will do a trial for 15 minutes and after that a blood gas analysis will be repeated: if the PaO2/FiO2 will be \< 200 the patient will go on with the control treatment; if PaO2 /FiO2 will be \>200, the patient will stop the treatment.

Sponsors

Agenzia Italiana del Farmaco
CollaboratorOTHER_GOV
University of Turin, Italy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients undergoing cardiac surgery on cardiopulmonary bypass * PaO2 /FiO2 \< 200 after extubation * extubation time \< 24 h.

Exclusion criteria

* patients \< 18 years old * extracorporeal membrane oxygenation * severe cardiac dysfunction (FE\<25%) * mechanical ventilation before the intervention * severe COPD (patients on oxygen therapy, with a FEV1\< 50%) * heart or lung transplantation * lack of consent.

Design outcomes

Primary

MeasureTime frame
rate of re-intubationat 28 days

Secondary

MeasureTime frame
incidence of pneumoniaat 28 days
incidence of sepsisat 28 days
incidence of atelectasisat 28 days
the intensive care unit length of stayat 28 days
hospital length of stayat 28 days
mortality rateat 28 days

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026